drugset / Trial / NCT02730689

A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone

NCT02730689

Phase 1 Completed 66 enrolled Alvogen Korea
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to compare the pharmacokinetics of DP-R207 (Rosuvastatin 10mg and Ezetimibe 10mg fixed dose combinations) in comparison to each component administered alone in health male volunteers.

Timeline

Start
2014-12
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject DP-R207 Unknown 10 mg
Subject Ezetimibe Unknown 10 mg
Subject Rosuvastatin Small molecule 10 mg

Indications

No indication recorded.